Functional exploration of the GH29 fucosidase family.
GH29
fucosidase
glycoengineering
glycosyl hydrolase
Journal
Glycobiology
ISSN: 1460-2423
Titre abrégé: Glycobiology
Pays: England
ID NLM: 9104124
Informations de publication
Date de publication:
20 08 2020
20 08 2020
Historique:
received:
05
12
2019
revised:
27
01
2020
accepted:
27
02
2020
pubmed:
10
3
2020
medline:
21
10
2021
entrez:
10
3
2020
Statut:
ppublish
Résumé
The deoxy sugar l-fucose is frequently found as a glycan constituent on and outside living cells, and in mammals it is involved in a wide range of biological processes including leukocyte trafficking, histo-blood group antigenicity and antibody effector functions. The manipulation of fucose levels in those biomedically important systems may provide novel insights and therapeutic leads. However, despite the large established sequence diversity of natural fucosidases, so far, very few enzymes have been characterized. We explored the diversity of the α-l-fucosidase-containing CAZY family GH29 by bio-informatic analysis, and by the recombinant production and exploration for fucosidase activity of a subset of 82 protein sequences that represent the family's large sequence diversity. After establishing that most of the corresponding proteins can be readily expressed in E. coli, more than half of the obtained recombinant proteins (57% of the entire subset) showed activity towards the simple chromogenic fucosylated substrate 4-nitrophenyl α-l-fucopyranoside. Thirty-seven of these active GH29 enzymes (and the GH29 subtaxa that they represent) had not been characterized before. With such a sequence diversity-based collection available, it can easily be used to screen for fucosidase activity towards biomedically relevant fucosylated glycoproteins. As an example, the subset was used to screen GH29 members for activity towards the naturally occurring sialyl-Lewis x-type epitope on glycoproteins, and several such enzymes were identified. Together, the results provide a significant increase in the diversity of characterized GH29 enzymes, and the recombinant enzymes constitute a resource for the further functional exploration of this enzyme family.
Identifiants
pubmed: 32149359
pii: 5788441
doi: 10.1093/glycob/cwaa023
pmc: PMC7116272
mid: EMS93765
doi:
Substances chimiques
Polysaccharides
0
Recombinant Proteins
0
FUCA2 protein, human
EC 3.2.1.51
alpha-L-Fucosidase
EC 3.2.1.51
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
735-745Informations de copyright
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
FEBS Lett. 2001 Mar 16;492(3):193-8
pubmed: 11257493
Biosci Biotechnol Biochem. 2012;76(5):1022-4
pubmed: 22738979
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Bacteriol. 2004 Aug;186(15):4885-93
pubmed: 15262925
Glycobiology. 2017 Jul 1;27(7):601-618
pubmed: 28430973
Nature. 2014 Oct 30;514(7524):638-41
pubmed: 25274297
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Mol Biol. 2001 Jan 19;305(3):567-80
pubmed: 11152613
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5234-9
pubmed: 12697902
J Biol Chem. 2002 Jul 26;277(30):26733-40
pubmed: 11986321
Glycoconj J. 1995 Jun;12(3):227-33
pubmed: 7496136
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Biochemistry. 2013 Aug 27;52(34):5857-64
pubmed: 23883131
Anal Chem. 2010 Sep 1;82(17):7408-15
pubmed: 20684520
J Immunol. 2008 Aug 15;181(4):2407-13
pubmed: 18684930
Nat Protoc. 2010 Apr;5(4):725-38
pubmed: 20360767
J Biol Chem. 2007 Jun 22;282(25):18497-509
pubmed: 17459873
J Immunol. 2015 Jun 15;194(12):5588-93
pubmed: 26048966
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
J Biol Chem. 2012 May 11;287(20):16709-19
pubmed: 22451675
ACS Chem Biol. 2017 Jan 20;12(1):63-72
pubmed: 28103685
Nucleic Acids Res. 2009 Jan;37(Database issue):D233-8
pubmed: 18838391
J Am Chem Soc. 2010 Feb 17;132(6):1804-6
pubmed: 20092273
J Clin Invest. 1995 Jun;95(6):2510-9
pubmed: 7539452
Nature. 2017 Apr 6;544(7648):65-70
pubmed: 28329766
Glycobiology. 2019 Jan 1;29(1):59-73
pubmed: 30544181
Glycobiology. 2009 Sep;19(9):1010-7
pubmed: 19520709
J Am Chem Soc. 2017 Oct 25;139(42):15074-15087
pubmed: 28990779
Science. 2011 Sep 23;333(6050):1761-4
pubmed: 21852454
J Biol Chem. 2003 Jan 31;278(5):3466-73
pubmed: 12427744
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
J Biol Chem. 2004 Mar 26;279(13):13119-28
pubmed: 14715651
Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81
pubmed: 25883148
Nat Med. 2002 Apr;8(4):366-72
pubmed: 11927942
Nat Protoc. 2006;1(1):397-405
pubmed: 17406262
Nat Commun. 2015 Jun 26;6:7481
pubmed: 26112186
Exp Dermatol. 2007 Jan;16(1):1-12
pubmed: 17181631
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
Acta Crystallogr F Struct Biol Commun. 2016 Oct 1;72(Pt 10):750-761
pubmed: 27710940
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7090-4
pubmed: 7624375
Nucleic Acids Res. 2014 Jan;42(Database issue):D490-5
pubmed: 24270786